Cerebrovascular accidents in sickle cell disease: Rates and risk factors

Blood

Volumn 91, Issue 1, 1998, Pages 288-294

  Ohene Frempong, Kwaku ^a   Weiner, Steven J ^b   Sleeper, Lynn A ^b   Miller, Scott T ^b   Embury, Stephen ^b   Moohr, John W ^b   Wethers, Doris L ^b   Pegelow, Charles H ^b   Gill, Frances M ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; DATA ANALYSIS; DISEASE ASSOCIATION; GENOTYPE; HEREDITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SICKLE CELL ANEMIA; STROKE; THALASSEMIA;

ADOLESCENT; ADULT; ALPHA-THALASSEMIA; ANEMIA, SICKLE CELL; BLOOD PRESSURE; CEREBROVASCULAR DISORDERS; CHEST PAIN; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; INCIDENCE; INFANT; ISCHEMIC ATTACK, TRANSIENT; MIDDLE AGED; PREVALENCE; RISK FACTORS; SYNDROME;

EID: 0031965089     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W: Mortality in children and adolescents with sickle cell disease. Pediatrics 84:500, 1989
2. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP: Mortality in sickle cell disease: Life expectancy and risk factors for early death. N Engl J Med 330:1639, 1994
3. Powars D, Wilson B, Imbus C, Pegelow C, Allen J: The natural history of stroke in sickle cell disease. Am J Med 65:461, 1978
4. Balkaran B, Char G, Morris JS, Thomas PW, Serjeant BE, Serjeant GR: Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr 120:360, 1992
5. Ohene-Frempong K: Stroke in sickle cell disease: Demographic, clinical and therapeutic considerations. Semin Hematol 28:213, 1991
6. Gaston M, Smith J, Gallagher D, Fluornoy-Gill Z, West S, Bellevue R, Farber M, Grover R, Koshy M, Ritchey AK, Wilimas J, and the CSSCD Group: Recruitment in the Cooperative Study of Sickle Cell Disease (CCSCD). Controlled Clin Trials 8:131S, 1987
7. Gaston M, Rosse WF, and the Cooperative Study of Sickle Cell Disease: The Cooperative Study of Sickle Cell Disease: Review of study design and objectives. Am J Pediatr Hematol Oncol 4:197, 1982
8. Farber MD, Koshy M, Kinney TR: Cooperative Study of Sickle Cell Disease: Demographic and socioeconomic characteristics of patients and families with sickle cell disease. J Chronic Dis 38:495, 1985
9. Adams JG III: Clinical laboratory diagnosis, in Embury SH, Hebbel RP, Mohandas N, Steinberg MH (eds): Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY, Raven, 1994, p 457
10. Wrightstone RN, Huisman TH: On the levels of hemoglobins F and A2 in sickle cell anemia and some related disorders. Am J Clin Pathol 61:375, 1974
11. Betke K, Marti HR, Schlicht I: Estimation of small percentages of foetal haemoglobin. Nature 184:1877, 1959
12. Embury SH, Lebo RV, Dozy AM, Kan YW: Organization of the single α-globin genes in the Chinese α-thalassemia syndromes. J Clin Invest 63:1307, 1979
13. Embury SH, Miller JA, Dozy AM, Kan YW, Chan V, Todd D: Two different molecular organizations account for the single α-globin gene in the α-thalassemia-2 genotype. J Clin Invest 66:1319, 1980
14. Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, Pegelow CH, Vichinsky E: Clinical events in the first decade in a cohort of infants with sickle cell disease. Blood 86:776, 1995
15. Kleinbaum DG, Kupper LL, Morgenstern H: Epidemiologic Research: Principles and Quantitative Methods. Belmont, CA, Lifetime Learning, 1982, p 284
16. Allison PD: Survival Analysis Using the SAS System: A Practical Guide. Cary, NC, SAS, 1995, p 259
17. Cnaan A, Ryan L: Survival analysis in natural history studies of disease. Stat Med 8:1255, 1989
18. Horton DP, Ferriero DM, Mentzer WC: Nontraumatic fat embolism in sickle cell anemia. Pediatr Neurol 12:77, 1995
19. Racoff WR, Ohene-Frempong K, Month S, Scott JP, Neahring B, Cohen AR: Neurologic events after partial exchange transfusion for priapism in sickle cell disease. J Pediatr 120:882, 1992
20. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR: Pain in sickle cell disease: Rates and risk factors. N Engl J Med 325:11, 1991
21. Castro O, Brambilla DJ, Thorington B, Reindorf CA, Scott RB, Gillette P, Vera JC, Levy PS: The acute chest syndrome in sickle cell disease: Incidence and risk factors. Blood 84:643, 1994
22. Prohovnik I, Pavlakis SG, Piomelli S, Bello J, Mohr JP, Hilal S, De Vivo DC: Cerebral hyperemia, stroke and transfusion in sickle cell disease. Neurology 39:344, 1989
23. Adams RJ: Neurologic complications, in Embury SH, Hebbel RP, Mohandas N, Steinberg MH (eds): Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY, Raven, 1994, p 599
24. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR: Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 332:1317, 1995
25. Adams RJ, Kutlar A, McKie V, Carl E, Nichols FT, Liu JC, McKie K, Clary A: Alpha thalassemia and stroke risk in sickle cell anemia. Am J Hematol 45:279, 1994
26. Piomelli S, Seaman C, Cirella B, Ince C, Meyer P, Paulakis S, Schaefer-Rego K, Bank A, Mears G: Does α-thalassemia protect from early stroke in sickle cell anemia? Pediatr Res 10:285A, 1986
27. Miller ST, Rieder RF, Rao SP, Brown AK: Cerebrovascular accidents in children with sickle-cell disease and alpha-thalassemia. J Pediatr 113:847, 1988
28. Russell MO, Goldberg HI, Hodson A, Kim HC, Halus J, Reivich M, Schwartz E: Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood 63:162, 1984
29. Sarnaik S, Soorya D, Kim J, Ravindranath Y, Lusher J: Periodic transfusions for sickle cell anemia and CNS infarction. Am J Dis Child 133:1254, 1979
30. Moohr JW, Wilson H, Pang EJM: Strokes and their management in sickle cell disease, in Fried W (ed): Comparative Clinical Aspects of Sickle Cell Disease. New York, NY, Elsevier North Holland, 1982, p 101
31. Wang WC, Kovnar EH, Tonkin IL, Mulhern RK, Langston JW, Day SW, Schell MJ, Wilimas JA: High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr 118:377, 1991
32. Pegelow CH, Adams RJ, McKie V, Abboud M, Berman B, Miller ST, Olivieri N, Vichinsky E, Wang W, Brambilla D: Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 126:896, 1995
33. Pavlakis SG, Bello J, Prohovnik I, Sutton M, Ince C, Mohr JP, Piomelli S, Hilal S, De Vivo DC: Brain infarction in sickle cell anemia: Magnetic resonance imaging correlates. Ann Neurol 23:125, 1988
34. Moser FG, Miller ST, Bello JA, Pegelow CH, Zimmerman RA, Wang WC, Ohene-Frempong K, Schwartz A, Vichinsky EP, Gallagher D, Kinney TR: The spectrum of central nervous system abnormalities in sickle cell disease as defined by magnetic resonance imaging: A report from the Cooperative Study of Sickle Cell Disease. Am J Neuroradiol 17:965, 1996
35. Wiznitzer M, Ruggieri PM, Masaryk TJ, Ross JS, Modic MT, Berman B: Diagnosis of cerebrovascular disease in sickle cell anemia by magnetic resonance angiography. J Pediatr 17:551, 1990
36. Adams R, McKie V, Nichols F, Carl E, Zhang DL, McKie K, Figueroa R, Litaker M, Thompson W, Hess D: The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 326:605, 1992